All Article articles – Page 72
-
Article
Bausch + Lomb confirms its organic growth
Due to strong sales in the second quarter, including better-than-expected organic growth at Bausch + Lomb, Bausch Health raised its adjusted Ebitda guidance for the full financial year. The Canadian group - previously called Valeant Pharmaceuticals - now expects it to be in the range of $3,200 to $3,350 million, ...
-
Article
Higher sales and margins for Hoya Vision Care
Hoya Corporation's revenues grew in its Life Care segment by 8.5 percent to 91.3 billion yen (€703.7m-$821.1m) for the first quarter of its financial year in reported terms, and by 10 percent on a currency-neutral basis. This segment, which represented around 65 percent of the Japanese group's quarterly revenues, includes ...
-
Article
Fielmann earns less
Fielmann hopes to turn around in the second half, in order to reach its forecast for a further increase in sales and profits for the full financial year. Germany's biggest optical retailer booked a net profit of €37.8 million in the second quarter of this year, down from €43.8 million ...
-
Article
Gentle Monster focuses on own retail in Europe
Gentle Monster, the big and creative eyewear brand from South Korea, opened its first European flagship store in London at the end of July, stirring a lot of excitement in the retail scene, way beyond the eyewear sector, because of its very special design and the development strategy behind it. ...
-
Article
Grandvision returns to growth in various markets
The G4 segment of GrandVision - which includes France, Luxembourg, Germany, Austria, Netherlands, Belgium, the U.K. and Ireland - returned to growth during the first half of the year, after several consecutive quarters of weakness following a change in health insurance reimbursements in France. In the first six months ended ...
-
Article
Italia Independent completes €4.89 million refinancing
To refinance itself again, Italia Independent completed on July 6 a €4.89 million rights issue under which shareholders could buy seven new shares for every 31 held at a price of €4 per share.Shareholders took up only 77.37 percent of the 1,221,500 shares, representing a total outlay of €3.78 million. ...
-
Article
Moody’s downgrades Safilo again
The rating agency downgraded Safilo's corporate family rating to B2 from B1 on concerns about delays in refinancing the eyewear maker's debt. More worryingly, Moody's changed its outlook for the company to negative from stable, indicating the possibility of a further downgrade.Moody's also cut its rating for the probability of ...
-
Article
Novartis will spin off Alcon
Novartis International has decided to let go of its eye care business, Alcon, keeping only its portfolio of pharmaceutical products. In January, the group had announced a strategic review of the division, which is now completed. After examining alternative options including a public offering for Alcon, the management determined that ...
-
Article
Luxottica buys Barberini
Luxottica is making yet another strategic move in the integration of lenses in its product line through the acquisition of Barberini, the Italian producer of high-end mineral lenses for sun and optical glasses, for about €140 million, after the start-up of its own lens factories in Italy and the U.S. ...
-
Article
Double-digit growth for J&J’s Vision Care
Johnson & Johnson's Vision Care division saw revenues jump by 11.2 percent to $1,173 million in the second quarter. The management said the division delivered strong results in both the contact lens and surgical businesses across key geographies, with operational growth of 9.6 percent.Sales of contact lenses rose by 11.1 ...
-
Article
Luxottica cleans up the distribution in Europe
Luxottica expects an acceleration in its organic sales growth to about 4 percent in the second half of this year, but the company nevertheless trimmed its top line guidance after a flattish first half.The group had previously projected that its sales would grow by between 2 and 4 percent this ...
-
Article
The Essilor-Luxottica merger is set to close in September
Essilor and Luxottica are expecting to close their merger agreement by the end of the third quarter now that the deal has been blessed by the Chinese government, after a long wait. The teams of the two companies have already started to work together to prepare the reorganization of the ...
-
Article
Essilor posts generally positive results
While announcing the approval of its combination with Luxottica by China's anti-trust authorities, which has removed the last hurdle for the creation of a new industry giant (see separate article in this issue), Essilor reported partially positive results for the first six months of this year, defining them as “healthy” ...
-
Article
New lens factory pledged for St. Petersburg
Unnamed Japanese investors plan to open a new lens manufacturing factory in St. Petersburg, in a joint venture with local companies, according to a Russian news agency, SPB Vedomosti, which cites sources in the Russian eyewear industry.The investment in the equipment required for the project is estimated at €10 million. ...
-
Article
Silmo Paris unveils some of the next show’s features
The organizers of Silmo Paris announced that the number of exhibitors for the next edition of the show will exceed 1,000 as 108 new companies have confirmed their participation so far, including more than twenty start-ups. De Rigo, the Italian eyewear group, and Menicon, the Japanese contact lens company are ...
-
Article
Steady growth for Specsavers
The international British-based optical retail chain reported annual revenues of £2,614 million (€2,935.4m-$3,429.0m) for its financial year ended in February, a 7 percent increase in constant currencies as compared to the previous year, when it had grown by 6.6 percent. In reported terms, Specsavers' global revenues grew by 15 percent, ...
-
Article
Safilo posts 6.9% higher sales in Q1
Safilo posted an encouraging 6.9 percent sales increase to €250.9 million in the first quarter of 2018, beating market expectations by nearly €12 million, and its profitability improved. At constant currency rates, sales were up by 15.4 percent and the increase reached 16.9 percent when excluding the Gucci business.The growth ...
-
Article
The European contact lens market grew again last year
In 2017, sales of soft contact lenses to eye-care professionals in Europe increased by 5.7 percent to €1,789 million, according to an annual study by the European Federation of National Associations and International Companies of Contact Lens and Lens Care Manufacturers (Euromcontact). The organization, which has been running a syndicated ...
-
Article
Earnings double at the former Allison
AVM 1959, or Allison Volta Mantovana, closed 2017 with a clear improvement in profits. According to the management, its Ebitda doubled to 10 percent of turnover, and the forecasts for 2018 calls for further growth. Sales grew by 2 percent to around €20 million.The company's return to profitability was one ...
-
Article
Valeant becomes Bausch Health Companies
Valeant Pharmaceuticals, the Canadian-based company that took over Bausch + Lomb five years ago with a total investment of $8.3 billion, will change its name next month to Bausch Health Companies, with a new corporate brand identity, new imagery, a new website and a new stock market ticker, BHC.The move ...
